Legal Representation
Attorney
Mark Wright
USPTO Deadlines
Next Deadline
1079 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-05)
Due Date
July 05, 2028
Grace Period Ends
January 05, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 7, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 18, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 18, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 5, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 5, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 5, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 3, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Apr 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 13, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Apr 13, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 30, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 14, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 11, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 10, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 10, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 10, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 10, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 11, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 10, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 10, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 25, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 27, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 27, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 14, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 13, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 8, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 11, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 3, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Reagents for scientific and research use, namely, reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes, namely, Diagnostic reagents and preparations, except for medical or veterinary use, Chemicals for use in industry and science, Chemical preparations for general industrial manufacturing; diagnostic reagents for scientific diagnostic not for medical and veterinary purposes; research reagents for scientific and diagnostic research purposes; diagnostic test materials for scientific and diagnostic purposes not for medical or veterinary purposes, namely, Diagnostic preparations, other than for medical or veterinary purposes, Diagnostic reagents for scientific or research use, Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemical reagents used for non-medical purposes; chemical reagents, other than for medical or veterinary purposes; biochemical diagnostic kits for scientific and diagnostic purposes not for medical or veterinary purposes comprised of biochemical reagents used for non-medical purposes; biochemical analysis kits for research and diagnostic purposes not for medical and veterinary purposes comprised of biochemicals for in vitro and in vivo scientific use; biochemical analysis preparations for scientific purposes related to vaccines and immunotherapy, including cancer therapy, cancer immunotherapy, analysis or treatment of cancer, infectious diseases and/or autoimmunity, and for use in connection with toxicological studies, transplantation, and immune monitoring and T cell monitoring
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Reagents for immunoanalysis for medical use; preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations for pharmaceutical or medical purposes; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; biochemical analysis preparations for medical purposes and the aforementioned preparations all for development and analysis of vaccines, immunotherapy and cellular therapy, namely, cancer vaccines and cancer immunotherapy, and T cell therapies; biochemical analysis preparations for pharmaceutical or medical purposes for use in cancer therapy or other therapy, for the analysis of T cell infiltration of solid tumors and tissue, as well as infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T cell monitoring, all for medical or veterinary purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and technological analyses of T cells and their responses, namely, research services and design of T cells and their responses; industrial analysis of T cells and their responses, including for development of medicines and vaccines; basic scientific and clinical research on T cells and their responses, including for the development of medicines and vaccines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042